Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CAMP4 Therapeutics Corpor...

    NASDAQ: CAMP · Real-Time Price · USD
    1.42
    -0.03 (-2.07%)
    At close: Jun 17, 2025, 3:35 PM

    CAMP4 Therapeutics Statistics

    Share Statistics

    CAMP4 Therapeutics has 20.16M shares outstanding. The number of shares has increased by 1121.26% in one year.

    Shares Outstanding

    n/a
    		 20.16M

    Shares Change (YoY)

    n/a
    		 1121.26%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 34.72%

    Shares Floating

    n/a
    		 2.64M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,730

    FTD / Avg. Volume

    n/a
    		 1.64%

    Short Selling Information

    The latest short interest is 491.22K, so 2.44% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 491.22K

    Short % of Shares Out

    n/a
    		 2.44%

    Short % of Float

    n/a
    		 8.71%

    Short Ratio (days to cover)

    n/a
    		 2.11

    Valuation Ratios

    The PE ratio is -1.97 and the forward PE ratio is -0.7. CAMP4 Therapeutics's PEG ratio is -0.35.

    PE Ratio

    n/a
    		 -1.97

    Forward PE

    n/a
    		 -0.7

    PS Ratio

    n/a
    		 156.16

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 1.61

    P/FCF Ratio

    n/a
    		 -2.21

    PEG Ratio

    n/a
    		 -0.35
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for CAMP4 Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.92, with a Debt / Equity ratio of 0.14.

    Current Ratio

    n/a
    		 6.92

    Quick Ratio

    n/a
    		 6.92

    Debt / Equity

    n/a
    		 0.14

    Debt / EBITDA

    n/a
    		 -0.17

    Debt / FCF

    n/a
    		 -0.19

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $11,854.55

    Profits Per Employee

    n/a
    		 $-941,654.55

    Employee Count

    n/a
    		 55

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is -0.61, so CAMP4 Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.61

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 1.99

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 28.18

    Average Volume (20 Days)

    n/a
    		 287,952

    Income Statement

    In the last 12 months, CAMP4 Therapeutics had revenue of 652K and earned -51.79M in profits. Earnings per share was -2.66.

    Revenue

    n/a
    		 652K

    Gross Profit

    n/a
    		 652K

    Operating Income

    n/a
    		 -53.09M

    Net Income

    n/a
    		 -51.79M

    EBITDA

    n/a
    		 -51.39M

    EBIT

    n/a
    		 -53.09M

    Earnings Per Share (EPS)

    n/a
    		 -2.66
    Full Income Statement

    Balance Sheet

    The company has 64.04M in cash and 8.65M in debt, giving a net cash position of 55.39M.

    Cash & Cash Equivalents

    n/a
    		 64.04M

    Total Debt

    n/a
    		 8.65M

    Net Cash

    n/a
    		 55.39M

    Retained Earnings

    n/a
    		 -211.75M

    Total Assets

    n/a
    		 62.77M

    Working Capital

    n/a
    		 45.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -45.56M and capital expenditures -441K, giving a free cash flow of -46M.

    Operating Cash Flow

    n/a
    		 -45.56M

    Capital Expenditures

    n/a
    		 -441K

    Free Cash Flow

    n/a
    		 -46M

    FCF Per Share

    n/a
    		 -2.36
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -8142.33% and -7943.4%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -8142.33%

    Pretax Margin

    n/a
    		 -7943.4%

    Profit Margin

    n/a
    		 -7943.4%

    EBITDA Margin

    n/a
    		 -7882.21%

    EBIT Margin

    n/a
    		 -8142.33%

    FCF Margin

    n/a
    		 -7055.67%

    Dividends & Yields

    CAMP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CAMP is $17.5, which is 1123.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $17.5

    Price Target Difference

    n/a
    		 1123.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 25, 1996. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Mar 25, 1996

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 -4.66

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist